These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11499859)

  • 1. Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group.
    Emerson A; Martin RM; Tomlin M; Mann RD
    Pharmacoepidemiol Drug Saf; 2001; 10(2):95-103. PubMed ID: 11499859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of adverse drug reactions detected by pharmacy and medical records departments.
    Johnstone DM; Kirking DM; Vinson BE
    Am J Health Syst Pharm; 1995 Feb; 52(3):297-301. PubMed ID: 7749958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.
    Haffner S; von Laue N; Wirth S; Thürmann PA
    Drug Saf; 2005; 28(5):453-64. PubMed ID: 15853446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education--2009.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2010 Apr; 67(7):542-58. PubMed ID: 20237382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2012.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2013 May; 70(9):787-803. PubMed ID: 23592362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an automated surveillance system using trigger alerts to prevent adverse drug events in the intensive care unit and general ward.
    DiPoto JP; Buckley MS; Kane-Gill SL
    Drug Saf; 2015 Mar; 38(3):311-7. PubMed ID: 25711668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in hospital in-patients: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2006 Aug; 31(4):335-41. PubMed ID: 16882102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacy service practice in a Chinese tertiary hospital.
    Chen B; Huang JJ; Chen HF; Xu BM
    Drug Metab Pers Ther; 2015 Dec; 30(4):215-30. PubMed ID: 26457791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.
    Olsen S; Neale G; Schwab K; Psaila B; Patel T; Chapman EJ; Vincent C
    Qual Saf Health Care; 2007 Feb; 16(1):40-4. PubMed ID: 17301203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerized physician order entry system combined with on-ward pharmacist: analysis of pharmacists' interventions.
    Bedouch P; Tessier A; Baudrant M; Labarere J; Foroni L; Calop J; Bosson JL; Allenet B
    J Eval Clin Pract; 2012 Aug; 18(4):911-8. PubMed ID: 21689216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study).
    Surgery and Pharmacy in Liaison (SUREPILL) Study Group
    Br J Surg; 2015 Sep; 102(10):1204-12. PubMed ID: 26179814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods.
    Zhai XB; Tian DD; Liu XY
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):220-9. PubMed ID: 25546163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist's management of drug-related problems: a tool for teaching and providing pharmaceutical care.
    Winslade NE; Bajcar JM; Bombassaro AM; Caravaggio CD; Strong DK; Yamashita SK
    Pharmacotherapy; 1997; 17(4):801-9. PubMed ID: 9250561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy-based antimicrobial-monitoring service.
    Berman JR; Zaran FK; Rybak MJ
    Am J Hosp Pharm; 1992 Jul; 49(7):1701-6. PubMed ID: 1621727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-managed monitoring of adverse reactions to contrast media.
    Damiani DR; Swanson DP
    Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
    Kuo GM; Touchette DR; Marinac JS
    Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.